tiprankstipranks
Trending News
More News >
Dingdang Health Technology Group Ltd. (HK:9886)
:9886
Hong Kong Market

Dingdang Health Technology Group Ltd. (9886) Stock Statistics & Valuation Metrics

Compare
0 Followers

Total Valuation

Dingdang Health Technology Group Ltd. has a market cap or net worth of ―. The enterprise value is HK$12.48B.
Market Cap
Enterprise ValueHK$12.48B

Share Statistics

Dingdang Health Technology Group Ltd. has 1,319,472,900 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,319,472,900
Owned by Insiders
Owned by Institutions

Financial Efficiency

Dingdang Health Technology Group Ltd.’s return on equity (ROE) is -0.23 and return on invested capital (ROIC) is -11.91%.
Return on Equity (ROE)-0.23
Return on Assets (ROA)-0.14
Return on Invested Capital (ROIC)-11.91%
Return on Capital Employed (ROCE)-0.12
Revenue Per Employee1.98M
Profits Per Employee-159.33K
Employee Count2,363
Asset Turnover1.77
Inventory Turnover5.48

Valuation Ratios

The current PE Ratio of Dingdang Health Technology Group Ltd. is -1.65. Dingdang Health Technology Group Ltd.’s PEG ratio is -0.06.
PE Ratio-1.65
PS Ratio0.00
PB Ratio5.62
Price to Fair Value0.37
Price to FCF-52.05
Price to Operating Cash Flow-59.95
PEG Ratio-0.06

Income Statement

In the last 12 months, Dingdang Health Technology Group Ltd. had revenue of 4.67B and earned -376.50M in profits. Earnings per share was -0.28.
Revenue4.67B
Gross Profit1.54B
Operating Income-215.18M
Pretax Income-370.12M
Net Income-376.50M
EBITDA-161.59M
Earnings Per Share (EPS)-0.28

Cash Flow

In the last 12 months, operating cash flow was -11.35M and capital expenditures -25.10M, giving a free cash flow of -36.45M billion.
Operating Cash Flow-11.35M
Free Cash Flow-36.45M
Free Cash Flow per Share-0.03

Dividends & Yields

Dingdang Health Technology Group Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.69
52-Week Price Change-50.00%
50-Day Moving Average0.45
200-Day Moving Average0.51
Relative Strength Index (RSI)52.46
Average Volume (3m)2.12M

Important Dates

Dingdang Health Technology Group Ltd. upcoming earnings date is Apr 1, 2026, Before Open (Confirmed).
Last Earnings DateSep 19, 2025
Next Earnings DateApr 1, 2026
Ex-Dividend Date

Financial Position

Dingdang Health Technology Group Ltd. as a current ratio of 2.65, with Debt / Equity ratio of 7.46%
Current Ratio2.65
Quick Ratio1.96
Debt to Market Cap0.00
Net Debt to EBITDA6.59
Interest Coverage Ratio0.00

Taxes

In the past 12 months, Dingdang Health Technology Group Ltd. has paid 9.87M in taxes.
Income Tax9.87M
Effective Tax Rate-0.03

Enterprise Valuation

Dingdang Health Technology Group Ltd. EV to EBITDA ratio is 2.75, with an EV/FCF ratio of 12.19.
EV to Sales-0.10
EV to EBITDA2.75
EV to Free Cash Flow12.19
EV to Operating Cash Flow39.14

Balance Sheet

Dingdang Health Technology Group Ltd. has HK$1.22B in cash and marketable securities with ¥152.61M in debt, giving a net cash position of -HK$1.07B billion.
Cash & Marketable SecuritiesHK$1.22B
Total Debt¥152.61M
Net Cash-HK$1.07B
Net Cash Per Share-HK$0.81
Tangible Book Value Per ShareHK$1.16

Margins

Gross margin is 33.49%, with operating margin of -4.61%, and net profit margin of -8.06%.
Gross Margin33.49%
Operating Margin-4.61%
Pretax Margin-7.93%
Net Profit Margin-8.06%
EBITDA Margin-3.46%
EBIT Margin-4.61%

Analyst Forecast

The average price target for Dingdang Health Technology Group Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast
EPS Growth Forecast

Scores

Smart ScoreN/A
AI Score
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis